A Phase 1/2 interventional study of Phenylephrine HCL and Phenylephrine HCL/Acetaminophen/Dimethindene Maleate in Heart Rate, Blood Pressure and Arrhythmias, sponsored by Novartis. Withdrawn at 1 site in Brazil. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2016-03-03.
Sponsored by Novartis · Phase 1/2 and Interventional
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Arrhythmias, Cardiac with a site in Brazil — 3 open to participants now, 4 under way, none of them phase 3. Arrhythmias, Cardiac · Brazil.
Among the 29 studies in Arrhythmias, Cardiac with a site in Brazil, this one is the 19th largest by enrollment of the 20 interventional ones that give a count, is the only one that started in 2010, is one of 2 in phase 1/2, and was the 6th registered.
1,051 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.
Browse Arrhythmias, Cardiac studies →3 of the 29 studies in Arrhythmias, Cardiac with a site in Brazil are open now. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 22+
Federal University of Piaui · Sites in Brazil
Ages 18+
University of Sao Paulo · Sites in Brazil
Ages 5–17 · Healthy volunteers
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 166 Arrhythmias, Cardiac studies recruiting now, 118 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 3 · Phase 4 5
First in 1995; this study’s year is marked. 1 started in 2010.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 65 across the 20 interventional studies, 100 across the 9 observational. Of the 16 that completed or were terminated, 5 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 29 have an industry lead sponsor. The 10 most frequent:
Novartis is the lead sponsor of 714 studies on the registry; none are open to participants now.
Novartis has 3 studies filed under Arrhythmias, Cardiac — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 29 studies in Arrhythmias, Cardiac with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate the safety of phenylephrine hydrochloride 10 mg + acetaminophen 500 mg + dimethindene maleate 1 mg compared to phenylephrine hydrocloride 10 mg alone in healthy volunteers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Phenylephrine HCL/Acetaminophen/Dimethindene Maleate
Drug: Phenylephrine HCL/Acetaminophen/Dimethindene Maleate
Phenylephrine hydrochloride 10mg
Drug: Phenylephrine HCL
Phenylephrine HCL 10mg
Drug pages: Phenylephrine · Acetaminophen · Dimethindene
Phenylephrine HCL 10mg/Acetaminophen 500mg/Dimethindene Maleate 1mg
To compare the effect of phenylephrine hydrochloride 10mg + acetaminophen 500mg + dimethindene maleate 1mg and phenylephrine hydrochloride 10mg alone on vital signs
Time frame: 15 days
Electrocardiographic (ECG) monitoring and evaluation of heart rhythm following dosing
Time frame: 15 days
To report and evaluate adverse events
Time frame: 15 days
The record gives a start of Sep 2010 and a primary completion of Nov 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Phenylephrine · Acetaminophen · Dimethindene